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Abstract cDNAs encoding novel long-chain scorpion toxins (64
amino acid residues, including only six cysteines) were isolated
from cDNA libraries produced from the venom glands of the
scorpions Androctonus australis from Old World and Tityus
serrulatus from New World. The encoded peptides were very
similar to a recently identified toxin from T. serrulatus, which is
active against the voltage-sensitive ‘delayed-rectifier’ potassium
channel, but they were completely different from the long-chain
and short-chain scorpion toxins already characterised. However,
there was some sequence similarity (42%) between these new
toxins, Aa TX KL and Ts TX KL, and scorpion defensins purified
from the hemolymph of Buthidae scorpions Leiurus quinques-
triatus and A. australis. Thus, according to a multiple sequence
alignment using CLUSTAL, these new toxins seem to be related
to the scorpion defensins.
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1. Introduction
Scorpion venoms are mixtures of many polypeptide compo-
nents, of which only a small proportion are lethal to mam-
mals. They are long-chain toxins containing 60 to 70 amino
acid residues and four disulphide bridges [1]. Their targets are
the voltage-sensitive Na channels of excitable nerve and
muscle cells and they can be classi¢ed into K-toxins, which
slow down Na channel inactivation [2], and L-toxins, which
a¡ect the channel activation process [3]. Other long-chain tox-
ins are speci¢cally lethal to either insects or crustaceans [4].
Short-chain toxins have also been found using an electrophys-
iological approach [5]. They act by blocking various voltage-
dependent or Ca2-activated K channels. These toxins con-
tain 31 to 38 amino acid residues and three or four disulphide
bridges [6^29]. The two classes of toxins share a common
structural framework consisting of a double-stranded anti-
parallel L-sheet linked to a short K-helix. This basic con¢gu-
ration including disulphide bridges is also found in the defen-
sins, produced by insects in response to body injury and to
prevent bacterial infection [30], and in plant Q-thionins [31].
A new scorpion toxin has been previously described, which
is active against a voltage-gated non-inactivating K channel,
but its full amino acid sequence has not yet been determined
[19,32]. It was puri¢ed from the South American scorpion
Tityus serrulatus and it is called tityustoxin KL (Ts TX KL).
Herein, a cDNA encoding Ts TX KL was ampli¢ed by PCR
and sequenced from a venom gland cDNA library of the
Brazilian scorpion T. serrulatus. Then, an analogue of Ts
TX KL was also characterised from a venom gland cDNA
library of the North African scorpion Androctonus australis.
The original primary structures depicted show an unusual
feature since these ‘long-chain’ scorpion toxins (8 kDa instead
of 3.5 to 4.5 kDa for the other scorpion toxins active on K
channels) are cross-linked by only three disulphide bridges.
2. Materials and methods
2.1. Materials
The following reagents were obtained from the indicated sources:
restriction enzymes from Bethesda Research Laboratories and New
England Biolabs; standard molecular biology reagents from Sigma
and Prolabo; K12 MC1061 and JM 109 E. coli strains from Pharma-
cia Biotech.; Sequenase from Amersham; agaroses from FMC; dNTP
from Perkin Elmer; BioTaq from Eurobio; Gene Clean kit from Bio
101; Wizard PCR Prep DNA Puri¢cation System from Promega.
2.2. Construction of the cDNA library
Standard recombinant DNA techniques were used [33]. The scor-
pions of the species T. serrulatus, collected near Santa Barbara, were a
gift from Dr. C.R. Diniz, Instituto E. Diaz, Belo-Horizonte, M.G
Brazil. The construction of the Vgt 10 cDNA library from telsons
has already been described in detail [34]. Five Wg of mRNA was
puri¢ed on an oligo (dT)-cellulose column (Clontech Laboratories)
after extraction from the venom gland by the guanidinium hot phenol
method [33]. The mRNA was inserted into EcoRI-cut Vgt 10 (Prom-
ega). The library contained 2.5U106 independent phage clones. The
Okayama-Berg cDNA library from telsons of A. australis scorpions
was constructed as previously described [35].
2.3. Polymerase chain reaction (PCR)
PCR was used as described [16] to screen the two libraries. Tem-
plate cDNA was puri¢ed on a Tip 100 Quiagen column from an
overnight 50 ml culture seeded with 1 ml of the library. Oligonucleo-
tide primers were synthesised using an Applied Biosystems model 391
DNA synthesiser and puri¢ed by ethanol precipitation. PCR products
were subjected to electrophoresis in a 3% Nusieve GTG/1% Seaplaque
agarose gel in TAE bu¡er and were puri¢ed using the Wizard PCR
Prep DNA Puri¢cation System. We obtained the 5P region of the Ts
TX KL cDNA by PCR using a degenerate reverse primer (degenerate
primer 1) 5P-CC(AG)AA(CT)TG(ACGT)GT(TC)TT(ACGT)GC(AC-
GT)AC(TC)TT-3P, corresponding to the residues Lys-21 to Gly-28 of
N-terminal amino acid sequence of Ts TX KL [19], and the forward
primer 5P-GAATTGGTCCGA CTTGAACGAGTT TTC-3P on the
Vgt 10 phage. The PCR product obtained was sequenced and a second
PCR was performed using the forward primer (primer 2) 5P-AAG
TTG GTG GCT TTA ATT CC-3P corresponding to residues Lys-1
to Pro-7 and the reverse primer 5P-ATGGGACCTTCTTTATGAG-
TATTCGGTGGAG-3P on the Vgt 10 phage. We obtained the 5P part
of the Aa TX KL cDNA, by PCR with the forward primer 5P-
GCTCTAAAAGCTGCTGCAGGG-3P on the Okayama-Berg plas-
mid and the degenerate reverse primer (degenerate primer 3) 5P-
(AG)TC(CT)TT(ACGT)GC(AG)CA(CT)TT(AG)CA(CT)TT-3P, the
sequence of which was based on the amino acid sequence of the Ts
TX KL precursor (residues Lys-54 to Asp-60; this work). This PCR
product (PCR 3) obtained was directly sequenced and two new PCR
(PCR 4 and 5) were carried out with the following sets of homologous
primers: (i) forward 5P-GCTCTAAAAGCTGCTGCAGGG-3P on the
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Okayama-Berg and reverse (primer 4) 5P-AAATCCGTGA-
CAAAAACCTTCTTC-3P on the Aa TX KL insert 3P end; (ii) for-
ward (primer 5) 5P-ACAAATGCTGTTCCAGTAGGTACT-3P on the
Aa TX KL insert 5P end and reverse 5P-CTGGATCCCTC-
GAGGCTGGTTCTTT-3P on the Okayama-Berg plasmid. PCR was
carried out as follows: total volume 50 Wl, 1 min denaturation at
94‡C, 1 min 30 annealing at 60‡C, 2 min 30 elongation at 72‡C, 40
cycles. The PCR fragments were directly sequenced. A ¢nal PCR
(PCR 6) was performed, using the library as template and homolo-
gous primers corresponding to the 5P and 3P non-coding regions ob-
tained by direct sequencing: (i) forward (primer 6) 5P-CATTTA-
CAGCTGGTTAACAGTCAACATGC-3P ; (ii) reverse (primer 7) 5P-
GTAATTGAAATTAAAATCCCAACCACTCGC-3P. The ampli¢ed
product was inserted into pBluescript SK and sequenced.
2.4. DNA sequence analysis
For direct sequencing of the PCR products, DNA was denaturated
at 100‡C for 3 min and rapidly cooled in liquid N2, then sequenced
with Sequenase, adding 1 Wl DMSO to the ¢rst 10 Wl reaction mixture
and diluting the labelling mix in DMSO. When required, the PCR
products were inserted into pBluescript SK using E. coli XL1-Blue
for plasmid propagation. The ends of the PCR products were blunted
with dNTPs, using the Klenow fragment. The PCR products were
then inserted into the PstI and EcoRV restriction sites of pBluescript
SK, and were sequenced [36] with Sequenase and the 17-base uni-
versal M13 primer.
2.5. Preparation of scorpion genomic DNA
Scorpion genomic DNA was puri¢ed from the muscle tissue of the
A. australis scorpion (three animals from Beni-Khedache and one
from Tozeur were used separately) as previously described [33,35].
2.6. Sequence analysis
Sequence analysis was carried out with PC/GENE and sequence
alignments with BISANCE [37]. CLUSTAL W (1.7) was used to
generate multiple sequence alignment. First, the four Def sequences
were aligned, then the pro¢le obtained used as input to the alignment
of the other sequences. The following parameters were used: for pair-
wise alignments, a gap open penalty (gop) of 10, a gap extension
penalty (gep) of 0.1; for multiple alignments, in the case of Def se-
quences, a gop of 1 and a gep of 0; and in the case of the other
sequences, a gap of 1 and a gep of 0.05; protein weight matrix BLO-
SUM30. The phylogeny inference package (PHYLIP, version 3.5 C),
was used to generate a distance matrix data using PROTDIST and
Dayho¡ PAM matrix; FITCH and DRAWTREE were used on the
distance matrix data to generate an unrooted tree, the input order of
species was randomised 30 times and the power was set to 2.
2.7. Mass spectrometry analysis
On-line Liquid-Chromatography ElectroSpray Mass Spectrometry
(LC-ES-MS) analysis of toxic fraction from T. serrulatus venom was
performed by Atheris Laboratories, Geneva, Switzerland.
2.8. Puri¢cation of Ts TX KL and determination of its N-terminal
sequence
After gel ¢ltration through Sephadex G-50, the toxic fraction was
loaded onto a Merck 4U250 mm analytical high pressure liquid chro-
matography (HPLC) column (Lichrospher, 5 Wm, 100 RP-18), as al-
ready described [11]. Automatic sequencing was as described [11].
3. Results and discussion
3.1. Sequences of cDNAs
The PCR strategy used to obtain the oligonucleotide se-
quences of Ts TX KL and Aa TX KL is described in Fig. 1.
The ¢rst PCR ampli¢ed a 250 bp fragment from the T. serru-
latus cDNA library. This was inserted between the SmaI and
EcoRI sites of pBluescript SK. Seven clones were sequenced.
The PCR insert encompassed the N-terminal part of the ma-
ture Ts TX KL, including part of a putative signal peptide
(amino acid residues 325 to +28). The fragment ampli¢ed by
the second PCR (315 bp) was inserted between the EcoRV
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Fig. 1. Strategy used to obtain the Ts TX KL and Aa TX KL cDNAs. A: PCR ampli¢cation of Ts TX KL cDNA. The arrows indicate the di-
rection of PCR ampli¢cation. The degenerate primer 1 is based on the partial Ts TX KL amino acid sequence (¢rst 45 amino acids) obtained
by Edman degradation [19] and is underlined above. X, unidenti¢ed amino acid; lowercase, con¢rmation required. Primer 2 is based on the nu-
cleotide sequence of the Ts TX KL cDNA determined by PCR 1. The cDNA was inserted into Vgt 10. B: PCR ampli¢cation of Aa TX KL
cDNA. The arrows indicate the direction of PCR ampli¢cation. Degenerate primer 3 corresponds to residues Lys-54 to Asp-60 of the Ts TX
KL cDNA as determined in A. Primers 4 and 5 are based on the oligonucleotide sequence of the fragment of the Aa TX KL cDNA obtained
by PCR 3. Primers 6 and 7, used to amplify the complete cDNA, are based on the nucleotide sequence of the 5P and 3P non-coding regions of
the Aa TX KL cDNA, as determined by PCR 4 and 5. The cDNA was inserted into the Okayama-Berg plasmid pcD-X. See Section 2 for
more details.
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and NotI restriction sites of pBluescript SK. Four clones
were analysed. These fragments together comprised a gene
encoding an 85 amino acids long Ts TX KL precursor (Fig.
2). Even in the longest insert analysed, no in-frame Met ini-
tiation codon was found, probably due to incomplete elonga-
tion during the cDNA synthesis by reverse transcriptase. The
deduced N-terminal amino acid sequence of the mature Ts TX
KL was completely consistent with the N-terminal sequence
previously obtained by Edman degradation [19]. The complete
sequence was 60 amino acids long and was very di¡erent from
those of the 60 to 70 residue toxins active against Na chan-
nels or those of the 30 to 40 residue toxins active against K
channels. Only the positions of the cysteines were similar,
suggesting a common disulphide bridge pattern. The ¢rst
Cys was at position +29, which is unusual for scorpion toxins.
The C-terminal residue should be not amidated because no
Gly was found before the stop codon [33,34]. We checked
whether this molecule was the ¢rst member of a new class
of toxins by looking for a possible analogue of Ts TX KL
in a cDNA library made from the A. australis venom gland.
No primary structure information was available in this case.
However, the Aa TX KL cDNA was ampli¢ed by PCR as
described in Section 2 and in Fig. 1. The PCR fragments
obtained were directly sequenced. Then the nucleotide se-
quence data were used to design primers 6 and 7 for the
ampli¢cation of the total cDNA encoding Aa TX KL. PCR
6 products were subcloned into pBluescript SK and se-
quenced (Fig. 2). There were 27 amino acid residues between
the ¢rst Met initiation codon and the N-terminal part of the
mature Aa TX KL protein, as determined by comparison with
the sequence of Ts TX KL [19]. The mature toxin should be
composed of 64 amino acid residues, cross-linked by six cys-
teine residues, with no Gly for amidation at the C-terminus.
PC/GENE predicted that the precursor would have a putative
signal peptide, di¡erent from those of the precursors of other
scorpion toxins active against Na or K channels [34]. This
putative peptide of 19 residues would be followed by a pro-
peptide of eight residues. The possible existence of a short
propeptide in the Ts TX KL and Aa TX KL precursors em-
phasises the similarity of these molecules to insect defensins,
which have a propeptide in their precursor. Moreover, pre-
liminary data from the PCR ampli¢cation of the Aa TX KL
gene from genomic DNA of four di¡erent animals suggested
that there are no introns present, based on the sizes of the
ampli¢ed fragments (data not shown). The insect defensin
genes are intronless [38].
On the 3P end, a putative polyadenylation site was identi¢ed
11 to 16 bp before the poly(A) track (not shown). The nucleo-
tide sequences of Ts TX KL and Aa TX KL were 66% iden-
tical.
3.2. Biochemical characterisation of Ts TX KL
On-line LC-ES-MS analysis of T. serrulatus venom (to be
published) was e⁄ciently used to detect Ts TX KL on the
basis of its atomic mass. A polypeptide with an experimental
mass of 6716.15 Da was detected. This was consistent with the
amino acid sequence predicted from the cDNA encoding Ts
TX KL, which gives a theoretical mass of 6716.76 Da. The N-
terminal sequence (eight amino acid residues) of this polypep-
tide, obtained by Edman degradation, was the same as that of
Ts TX KL already described [19].
3.3. Amino acid sequence analysis
The amino acid sequences of these two new toxins were
compared to each other (61% similarity between Ts TX KL
and Aa TX KL) and with those of other scorpion toxins able
to block various types of K channels [6^29], defensins puri-
¢ed from the hemolymph of the Buthidae scorpions Leiurus
quinquestriatus or A. australis [39,40] and of two insect orders
(Diptera and Odonata) [41]. Surprisingly, these two new tox-
ins have some segments similar to those of scorpion defensins.
Sixteen residues could be aligned between these defensins and
the 38 residues of the C-terminal part of the Aa TX KL,
giving 42% identity (Fig. 3A). Phylogeny clustered the sequen-
ces into three groups: (i) the toxins of about 4.5 kDa in size,
blockers of various voltage-activated K channels and of the
high conductance Ca2-activated K channels; (ii) the toxins
6 4 kDa in size, speci¢c blockers of the apamine-sensitive
Ca2-activated K channels; (iii) Ts TX KL, Aa TX KL
and the scorpion defensins, related to insect defensins [41].
There were no apparent di¡erences between toxins of di¡erent
geographical origins (Old versus New World). So, the phylog-
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Fig. 2. Nucleotide sequences of cDNAs and predicted protein se-
quences of Ts TX KL and Aa TX KL : Ts-5PCl.14, sequence of the
5P part of clone 14 of the Ts TX KL cDNA of Tityus serrulatus ob-
tained by PCR 1 (see Fig. 1A); Ts-3PCl.3, sequence of the 3P part
of clone 3 of the Ts TX KL cDNA of Tityus serrulatus obtained by
PCR 2 (see Fig. 1A); Aa-PCR cDNA, full sequence of the Aa Ts
KL cDNA (four clones sequenced) obtained by PCR 6 (see Fig.
1B); sequences are aligned for maximum identity. The putative
poly(A) signal AATAAA is underlined.
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eny analysis shows that Ts TX KL, Aa TX KL and insect
defensins belong to a monophyletic group (Fig. 3B).
Taking into account the sequence alignment of the six cys-
teines as reference and because these residues are consensual
between the scorpion toxins and insect defensins, it may be
speculated that the conformation of the residues 24 to 61 core
of Aa TX KL is the same as for charybdotoxin, with an K-
helix (two-and-an-half turns) and a triple-stranded anti-paral-
lel L-sheet [30]. Therefore, the scorpion toxin core might be
perfectly conserved in Aa TX KL. The new sequence data
suggest that scorpions produce toxin homologues in their ve-
noms, which are structurally diverse due to their N- and C-
terminal extensions protruding from a common structural
core. Toxins are mostly minor venom components, so the
question arises as to how such structural diversity is of pos-
itive evolutionary value? The Ts TX KL and Aa TX KL are
the ¢rst scorpion toxins described with more than 60 amino
acid residues but only three disulphide bridges. Are they a link
between the long-chain toxins active against voltage-sensitive
Na channels and the short-chain scorpion toxins active
against K channels? A way of evolution from three to four
disulphide bridges and, thus, from one speci¢city to another?
One thing seems clear to us: these two new toxins have se-
quences very similar to those of scorpion defensins, support-
ing the idea that scorpion toxins and defensins may be derived
from a common ancestral molecule.
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Fig. 3. Comparison of the amino acid sequences of short-chain toxins active against various types of K channel [6^29], the Ts TX KL and
Aa TX KL toxins (this work), the scorpion defensins from Leiurus quinquestriatus [39] and Androctonus australis [40] and defensins from two
insect orders (Diptera and Odonata) [41]. A: Multiple sequence alignment. Ligands of the apamine binding site and their analogues: LTX1,
Leiurotoxin 1 (ScTX, Scyllatoxin) from Leiurus quinquestriatus hebraeus [6,7]; P05 and P01 from Androctonus mauretanicus mauretanicus [8,9] ;
BmP01, BmP02, BmP03, BmP05 from Buthus martenzi [10]; Ts U from Tityus serrulatus [11]. Short toxins cross-linked by four disulphide
bridges: Pi 1 from Pandinus imperator [12]; MTX, Maurotoxin from Scorpio maurus palmatus [13]; HsTX1 from Heterometrus spinnifer [14].
Ligands of others types of potassium channels: KTX, Kaliotoxin from Androctonus mauretanicus mauretanicus [15] ; KTX2, Kaliotoxin 2 from
Androctonus australis [16]; BmKTX, BmTX1 and BmTX2, Kaliotoxin and toxins 1 and 2 from Buthus martenzi [17] ; AgTX1, AgTX2, AgTX3,
Agitoxin 1, 2 and 3 from Leiurus quinquestriatus hebraeus [18]; Ts TX-KK from Tityus serrulatus [19]; MgTX, Margatoxin from Centruroides
margaritus [20]; NTX, Noxiustoxin from Centruroides noxius [21]; NTX2, Noxiustoxin 2 from Centruroides noxius [22] ; PiTX-KK and PiTX-
KL from Pandinus imperator [23]; ClTX from Centruroides limpidus limpidus [24]; IbTX, Iberiotoxin from Buthus tamulus [25]; ChTX, Charyb-
dotoxin, Lq2 and Lq18-2 or Lq15-1 from Leiurus quinquestriatus hebraeus, respectively [26^28]; OsK-1 from Orthochirus scrobiculosus [29]. Ts
TX KL and Aa TX KL (this work). Lq Def and Aa Def, sequences of the scorpion defensins from Leiurus quinquestriatus and from Androcto-
nus australis respectively [39,40]. Aeschna Def, PhormiaA Def, Sarcophaga Def, insect defensins from Aeschna (Odonata), Phormia and Sar-
cophaga (Diptera) [41]. Z, pyroglutamic acid. B: Phylogeny. Input distance matrix data correspond to sequence alignment of A.
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